Direkt zum Inhalt
Merck
  • Down-regulation of inflammatory mediator synthesis and infiltration of inflammatory cells by MMP-3 in experimentally induced rat pulpitis.

Down-regulation of inflammatory mediator synthesis and infiltration of inflammatory cells by MMP-3 in experimentally induced rat pulpitis.

Journal of endodontics (2014-08-26)
Koyo Takimoto, Nobuyuki Kawashima, Noriyuki Suzuki, Yu Koizumi, Mioko Yamamoto, Misako Nakashima, Hideaki Suda
ZUSAMMENFASSUNG

Matrix metalloproteinase (MMP)-3 is a member of the MMP family that degrades the extracellular matrix. Application of MMP-3 to injured pulp tissue induces angiogenesis and wound healing, but its anti-inflammatory effects are still unclear. Here, we evaluated the anti-inflammatory functions of MMP-3 in vitro and in vivo. Nitric oxide and inflammatory mediator synthesis in macrophages activated by lipopolysaccharide (LPS) was measured in the presence or absence of MMP-3. The mouse Mmp3 (mMmp3) expression vector containing full length cDNA sequence of mMmp3 or cDNA sequence of mMmp3 missing the signal peptide and pro-peptide regions was transfected to RAW264, a mouse macrophage cell line, and NO synthesis and inflammatory mediator expression were evaluated. Pulpal inflammation was histologically and immunohistochemically evaluated in a rat model of incisor pulpitis induced by the application of LPS for 9 hours in the presence or absence of MMP-3. NO and pro-inflammatory mediator synthesis promoted by LPS was significantly down-regulated by MMP-3 in vitro. The full length of mMmp3 down-regulated the LPS-induced NO synthesis and chemical mediator mRNA expression, however the mMmp3 missing the signal peptide failed to block the NO synthesis induced by LPS. The numbers of major histocompatibility complex class II+ and CD68+ cells, which infiltrated into the rat incisor pulp tissues in response to the topical application of LPS, were significantly decreased by the application of MMP-3 in vivo. These results indicate that MMP-3 possesses anti-inflammatory functions, suggesting its potential utility as an anti-inflammatory agent for pulpal inflammation.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Hexan, suitable for HPLC, ≥97.0% (GC)
Sigma-Aldrich
Hexan, ReagentPlus®, ≥99%
Sigma-Aldrich
Hexan, suitable for HPLC, ≥95%
Sigma-Aldrich
Hexan, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99% (GC)
Sigma-Aldrich
Hexan, HPLC Plus, for HPLC, GC, and residue analysis, ≥95%
Sigma-Aldrich
Hexan, Laboratory Reagent, ≥95%
Sigma-Aldrich
Sulfanilamid, ≥98%
Sigma-Aldrich
Hexan, anhydrous, 95%
Supelco
Hexan, analytical standard
Supelco
Sulfanilamid Schmelzpunktstandard, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Sulfanilamid, puriss. p.a., ≥98% (calc. to the dried substance)
Sigma-Aldrich
Anti-V5-Antikörper, Maus monoklonal, clone V5-10, purified from hybridoma cell culture
USP
Sulfanilamid, United States Pharmacopeia (USP) Reference Standard
USP
Sulfanilamid, United States Pharmacopeia (USP) Reference Standard
Supelco
Sulfanilamid, VETRANAL®, analytical standard
Sulfanilamid, European Pharmacopoeia (EP) Reference Standard